Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Race, gender and mutations in the prediction of anti-EGFR activity.

Future oncology (London, England) - 1 Apr 2005

Jimeno Antonio

Abstract excerpt

Evaluation of: Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, Mitsudomi T: Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res. 64(24), 8919-8923 (2004).

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Carcinoma, Non-Small-Cell Lung
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, erbB-1

Share to Genes, p53

Share to Genes, ras

Share to Racial Groups

Share to Sex Factors

Source

Identifiers

PMID: 16555991
DOI: 10.1517/14796694.1.2.201

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Race, gender and mutations in the prediction of anti-EGFR activity.PMID 16555991Read ↗

EGFR mutations and EGFR tyrosine kinase inhibitors.Semantic proximity Read ↗

Role of epidermal growth factor receptor mutations in predicting sensitivity or resistance to targeted agents in non-small-cell lung cancer.Semantic proximity Read ↗

Biological and clinical features in predicting efficacy of epidermal growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysis.Semantic proximity Read ↗

The role of the molecular footprint of EGFR in tailoring treatment decisions in NSCLC.Semantic proximity Read ↗

Frequency of and variables associated with the EGFR mutation and its subtypesSemantic proximity Read ↗

Epidermal growth factor receptor in relation to tumor development: EGFR-targeted anticancer therapy.Semantic proximity Read ↗

Clinical aspects of epidermal growth factor receptor inhibitors: benefit and risk.Semantic proximity Read ↗

The impact of epidermal-growth-factor-receptor mutations in response to lung-cancer therapy.Semantic proximity Read ↗

Predictive factors for epidermal growth factor receptor inhibitors--the bull's-eye hits the arrow.Semantic proximity Read ↗

Are there any ethnic differences in molecular predictors of erlotinib efficacy in advanced non-small cell lung cancer?Semantic proximity Read ↗

Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung CancersSemantic proximity Read ↗

[Gene mutation (KRAS, BRAF, PIK3CA) and clinical benefit of anti-EGFR antibody].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.